Weekly Paclitaxel for Recurrent Ovarian Cancer: Does Weekly Administration at Primary Diagnosis Impact Efficacy and Toxicity at Recurrence?
- Resource Type
- Abstract
- Source
- In
Gynecologic Oncology October 2016 143(1):204-204 - Subject
- Language
- ISSN
- 0090-8258